6
edits
m
robot: Update article (please report if you notice any mistake or error in this edit)
>ZI Jony m (v2.04b - Fix errors for CW project (Template contains useless word template:)) |
m (robot: Update article (please report if you notice any mistake or error in this edit)) |
||
| Line 21: | Line 21: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
* [http://articles.economictimes.indiatimes.com/keyword/international-finance-corporation Articles about International Finance Corporation | * [http://articles.economictimes.indiatimes.com/keyword/international-finance-corporation Articles about International Finance Corporation – Economic Times<!-- Bot generated title -->] | ||
* [https://web.archive.org/web/20111102220924/http://biospectrumindia.ciol.com/content/CoverStory/111101113.asp BioSpectrumIndia | * [https://web.archive.org/web/20111102220924/http://biospectrumindia.ciol.com/content/CoverStory/111101113.asp BioSpectrumIndia – the business of biotech – Customer relationships in a competitive market<!-- Bot generated title -->] | ||
* [http://www.business-standard.com/india/news/elephant-capital-buys-stake-in-clintec-intl-for-rs-58-cr/105952/on Elephant Capital buys stake in ClinTec Intl for Rs 58 cr<!-- Bot generated title -->] | * [http://www.business-standard.com/india/news/elephant-capital-buys-stake-in-clintec-intl-for-rs-58-cr/105952/on Elephant Capital buys stake in ClinTec Intl for Rs 58 cr<!-- Bot generated title -->] | ||
* [https://web.archive.org/web/20120827052720/http://www.biospectrumasia.com/biospectrum/opinion/3204/cosmetics-testing-kills-million-animals#.UEuw9rLiZi9 Cosmetics testing kills 3.9 million animals - BioSpectrum Asia<!-- Bot generated title -->] | * [https://web.archive.org/web/20120827052720/http://www.biospectrumasia.com/biospectrum/opinion/3204/cosmetics-testing-kills-million-animals#.UEuw9rLiZi9 Cosmetics testing kills 3.9 million animals - BioSpectrum Asia<!-- Bot generated title -->] | ||
| Line 28: | Line 28: | ||
* [http://www.business-standard.com/india/news/dabur-to-re-expand-its-pharma-research/382968/ Dabur to re-expand its pharma research<!-- Bot generated title -->] | * [http://www.business-standard.com/india/news/dabur-to-re-expand-its-pharma-research/382968/ Dabur to re-expand its pharma research<!-- Bot generated title -->] | ||
== | ==Review of Literature == | ||
* {{cite journal |doi=10.1007/s12094-012-0883-2 |title=Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel |year=2012 |last1=Madaan |first1=Alka |last2=Singh |first2=Pratibha |last3=Awasthi |first3=Anshumali |last4=Verma |first4=Ritu |last5=Singh |first5=Anu T. |last6=Jaggi |first6=Manu |last7=Mishra |first7=Shiva Kant |last8=Kulkarni |first8=Sadanand |last9=Kulkarni |first9=Hrishikesh |journal=Clinical and Translational Oncology |volume=15 |issue=1 |pages=26–32 |pmid=22855169 }} | * {{cite journal |doi=10.1007/s12094-012-0883-2 |title=Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel |year=2012 |last1=Madaan |first1=Alka |last2=Singh |first2=Pratibha |last3=Awasthi |first3=Anshumali |last4=Verma |first4=Ritu |last5=Singh |first5=Anu T. |last6=Jaggi |first6=Manu |last7=Mishra |first7=Shiva Kant |last8=Kulkarni |first8=Sadanand |last9=Kulkarni |first9=Hrishikesh |journal=Clinical and Translational Oncology |volume=15 |issue=1 |pages=26–32 |pmid=22855169 }} | ||
* {{cite journal |doi=10.1080/14756360802696802 |title=Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives |year=2009 |last1=Kumar |first1=Vivek |last2=Madaan |first2=Alka |last3=Sanna |first3=Vinod K. |last4=Vishnoi |first4=Manupriya |last5=Joshi |first5=Narendra |last6=Singh |first6=Anu T. |last7=Jaggi |first7=Manu |last8=Sharma |first8=Pramod K. |last9=Irchhaiya |first9=Raghuveer |last10=Burman |first10=Anand C. |journal=Journal of Enzyme Inhibition and Medicinal Chemistry |volume=24 |issue=5 |pages=1169–78 |pmid=19555167|display-authors=8 }} | * {{cite journal |doi=10.1080/14756360802696802 |title=Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives |year=2009 |last1=Kumar |first1=Vivek |last2=Madaan |first2=Alka |last3=Sanna |first3=Vinod K. |last4=Vishnoi |first4=Manupriya |last5=Joshi |first5=Narendra |last6=Singh |first6=Anu T. |last7=Jaggi |first7=Manu |last8=Sharma |first8=Pramod K. |last9=Irchhaiya |first9=Raghuveer |last10=Burman |first10=Anand C. |journal=Journal of Enzyme Inhibition and Medicinal Chemistry |volume=24 |issue=5 |pages=1169–78 |pmid=19555167|display-authors=8 }} | ||